SNSS Sunesis Pharmaceuticals Inc

Sunesis Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers.

$4.28
As of 02/23/2021     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Micro cap
Health Care
Biotechnology
USA
USA
09/27/2005
18,093,000
3,268,501
$77,438,040
0.00%
SEC Edgar Online
10-Q
10-K
867328874
US8673288747
BN2BFR3

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-7.00
4.09
35.31
-90.29%
-1,007.30%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy